FDA Adverse Event Injury Summary report: N

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 2843029 · Received November 21, 2012

Report

Report Number
2024168-2012-07402
Event Type
Injury
Date Received
November 21, 2012
Date of Event
May 15, 2012
Report Date
October 29, 2012
Manufacturer
AV-TEMECULA-CT
Product Code
NIQ
PMA / PMN Number
P070015
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4): DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. THERE WERE NO REPORTED PRODUCT DEFICIENCIES. THE REPORTED PATIENT EFFECTS OF ANGINA AND RESTENOSIS ARE LISTED IN THE XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM INSTRUCTIONS FOR USE, AS KNOWN ADVERSE EVENTS. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECTS AND THE RELATIONSHIP TO THE DEVICE, IF ANY, CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE, DESIGN, OR LABELING.

Description of Event or Problem · 1

IT WAS REPORTED THAT ON (B)(6) 2008, A XIENCE V STENT WAS IMPLANTED IN A DE NOVO, MID, LEFT ANTERIOR DESCENDING CORONARY ARTERY AND ON (B)(6) 2012 THE PATIENT EXPERIENCED ANGINA AND WAS ADMITTED TO THE HOSPITAL. A DIAGNOSTIC CORONARY ANGIOGRAPHY WAS DONE WITH FINDINGS OF 100% OCCLUDED MID LAD. AN ELECTIVE LEFT INTERNAL MAMMARY ARTERY (LIMA)- LAD, SAPHENOUS VEIN GRAFT (SVG)-DIAGONAL, SVG-OBTUSE MARGINAL, AND SVG-POSTERIOR DESCENDING CORONARY ARTERY BYPASS SURGERY WAS COMPLETED ON (B)(6) 2012 AND THE SYMPTOMS RESOLVED ON (B)(6) 2012. THE PATIENT WAS DISCHARGED HOME ON (B)(6) 2012 WITHOUT ANY PATIENT ADVERSE SEQUELA. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM DRUG ELUTING CORONARY STENT SYSTEM NIQ AV-TEMECULA-CT 7112141

Patients

Seq Age Sex Outcome Treatment
1 76 YR Hospitalization| R| S